Targeted inhibition of colorectal carcinoma using a designed CEA-binding protein to deliver TCF/LEF transcription factor decoy DNA and p53 protein
Wang, W.; Sun, X.; Wu, G.
Show abstract
Colorectal carcinoma (CRC) is characterized by mutations in Wnt signaling pathway components and the p53 protein, and anti{square}PD-1/anti{square}PD-L1 immunotherapy has shown limited efficacy in microsatellite stable CRC patients. In this work, CEABP1, a de novo-designed binding protein for the CRC marker carcinoembryonic antigen (CEA), and cell-penetrating peptide (CPP) were employed for targeted delivery in CRC cells. The consensus binding motifs for TCF/LEF and Max were concatenated, and Max DNA binding domain protein fused with CPP and CEABP1 was used to deliver this TCF/LEF transcription factor decoy (TFD) DNA specifically into CRC cells by recognizing CEA on the CRC cell surface to inhibit Wnt target gene transcription, leading to marked suppression of CRC cell proliferation and xenograft tumor growth. In addition, p28 was employed as a CPP to specifically deliver the p28-p53-CEABP1 protein into CRC cells, which significantly enhanced p53 inhibition of CRC cell proliferation and xenograft tumor growth. Furthermore, codelivery of the p14ARF protein together with p53 increased its antitumor activity by prolonging its effective duration. These findings paved the way for the development of related biomacromolecular anticancer therapeutics.
Matching journals
The top 12 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Development of 5-FU-modified tumor suppressor microRNAs as a platform for novel microRNA-based cancer therapeutics 95%
- circMRPS35 promotes malignant progression and cisplatin resistance in hepatocellular cancer 94%
- A novel anti-PD-L1/IL-15 immunocytokine overcomes resistance to PD-L1 blockade and elicits potent antitumor immunity 93%
Similar papers in this journal
- Discovery of intratumoral oncolytic bacteria toward targeted anticancer theranostics 95%
- TSHR-targeting nucleic acid aptamer treats Graves' ophthalmopathy via novel allosteric inhibition 95%
- Massively parallel screening of TIR-derived peptides reveals vast TLR-targeting immunomodulatory peptides 94%
Similar papers in this journal
- Selective targeting of an oncogenic KRAS mutant allele by CRISPR/Cas9 induces efficient tumor regression 95%
- Metabolic remodeling by TIGAR overexpression is a therapeutic target in esophageal squamous-cell carcinoma 92%
- Claudin-5 binder enhances focused ultrasound-mediated opening in an in vitro blood-brain barrier model 92%
Similar papers in this journal
- CoVac501, a self-adjuvanting peptide vaccine conjugated with TLR7 agonists, against SARS-CoV-2 induces protective immunity 94%
- Lyophilized mRNA-lipid nanoparticle vaccines with long-term stability and high antigenicity against SARS-CoV-2 93%
- Broad ultra-potent neutralization of SARS-CoV-2 variants by monoclonal antibodies specific to the tip of RBD 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.